Anavex Life Sciences Corp (AVXL)

[TTTav66]

May 20-21, Dr. Missling will deliver a presentation and participate in a panel discussion at the Protein Misfolding Drug Discovery conference in Boston, MA. https://protein-misfolding.com/

May 20 presentation: Cross-Learnings from Mechanisms of Action Underlying Protein Conformational Disorders, 2:30pm
• How to evaluate the safety and tolerability of novel protein misfolding therapeutics as assessed through clinical development
• How can the commonalities in underlying molecular pathology be used to inform the development of new treatment options for protein-misfolding diseases?
• How can you leverage a clinical developmental strategy to address a range of diseases caused by protein misfolding for which no approved disease-modifying treatments currently exist?

May 21 panel discussion: Conducting a Strategic Analysis of Protein Misfolding Therapeutics, 2pm
• What key learnings can be applied from clinical successful companies in this space?
• What change do you want to see in this space from both large pharma and biotech companies to accelerate robust candidates into the clinic?
• Where are the key opportunities for money flow, partnerships and collaborations to accelerate scientific progress?
• What is the market opportunity and unmet need that makes protein misfolding therapeutics an attractive but high hanging fruit in terms of therapeutic potential?

Program quote from Missling:
“Excited to share insights into advancement of clinical findings relevant to the scientific community and the patient population affected by the respective diseases”


February 11 : BIO CEO & Investor Conference - New York, NY
-Company presentation - 1:30pm (webcast anticipated)
-Panel discussion with Dr. Missling—Neuroscience at the Crossroads: Late Stage Brain Disorder Pipelines and Unmet Needs - 3pm
-Anavex also listed under Partnering Companies
https://www.bio.org/events/bio-ceo-investor-conference/sessions/628948

------------------

March 13 : 2020 Epilepsy Pipeline Conference - Santa Clara, CA
Dr. Walter E. Kaufmann presenting during the Rare and Ultra-Rare Diseases session on Day 2 - 1:25-3:25 P.M
https://www.epilepsy.com/make-difference/research-and-new-therapies/engagement/2020-epilepsy-pipeline-conference

------------------

May 5-6 : World BI: 16th Clinical Trials Innovation Programme - Boston, MA
Daniel Klamer listed as a featured speaker
https://worldbigroup.com/conference/sixteen-clinical-trials/
(note: the four featured speakers were rotated on conference site) Original four here: https://industryevents.com/events/16th-clinical-trials-innovation-programme-in-boston-ma

------------------

May 20-21 : Protein Misfolding Drug Discovery - Boston, MA
-Presentation: Cross-Learnings from Mechanisms of Action Underlying Protein Conformational Disorders - Dr. Missling, 2:30pm
-Panel Discussion: Conducting a Strategic Analysis of Protein Misfolding Therapeutics - w/Dr. Missling, 2pm
https://protein-misfolding.com/

------------------

June 3-4 : Microbiome Connect Human USA - Boston, MA
Dr. Missling listed as a speaker
https://www.humanmicrobiomecongress.com/events/microbiome-congress-usa-2020-0#speakers
(note: the Agenda available for download is a sample agenda from a previous conference)